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Microcirculatory alterations are frequently observed in critically ill patients undergoing major surgery and those who
suffer from trauma or sepsis. Despite the need for adequate fluid administration to restore microcirculation, there is
no consensus regarding optimal fluid therapy for these patients. The recent recognition of the importance of the
endothelial glycocalyx layer in capillary fluid and solute exchange has largely changed our views on fluid therapy in
critical illness. Given that disease status largely differs among critically ill patients, fluid therapy must not be considered
generally, but rather tailored to the clinical condition of each patient. This review outlines the current understanding
of context-sensitive volume expansion by fluid solutions and considers its clinical implications for critically ill patients.
The modulation of capillary hydrostatic pressure through the appropriate use of vasopressors may increase the
effectiveness of fluid infusion and thereby reduce detrimental effects resulting from excessive fluid administration.
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Introduction
In critically ill patients, including high-risk patients
undergoing major surgery and patients with trauma or
sepsis, adequate fluid administration is essential for the
maintenance of tissue perfusion. Nevertheless, there is
no consensus regarding the optimal fluid therapy (e.g.,
fluid type, volume, and timing of administration) for
these patients [1]. Hydroxyethyl starch (HES) solutions
are widely used to restore intravascular volume in high-
risk patients undergoing anesthesia for major surgery,
but the use of HES during perioperative period is con-
troversial because of potential adverse events including
renal dysfunction [2]. In traumatic patients, the question
remains whether limiting volumes of early resuscitation
with permissive hypotension improves outcomes from
trauma [3]. The benefit of early goal-directed bolus fluid
therapy in septic patients has been reappraised in recent
treatment bundles for septic care [3].
Key features of fluid therapy in critical illness are
vascular content (i.e., intravascular volume), vascular
tone (i.e., vasoconstriction or vasodilation), and capillary
permeability determined by endothelial integrity [4].
Surgical insults and severe infections affect all of these
features, the magnitudes of which depend on clinical
context such as the phase of illness. For example, fluid
administration increases mean systemic filling pressure
through intravascular volume expansion, thus increasing
venous return and cardiac output [5, 6]. However, the
degree of intravascular volume expansion is context-
sensitive as demonstrated by larger plasma volume expan-
sion following fluid infusion in the hypovolemic state
compared to the normovolemic state [7].
Critically ill patients show a wide variety of patho-
physiological conditions, severity of disease, and phase
of progress. Thus, consideration of the context-sensitive
volume effects of fluids may shed light on the long-




Endothelial glycocalyx and endothelial surface layer
The endothelium is covered with a gel-like layer of endo-
thelial glycocalyx (EG), which is a luminal coat of biopoly-
mers forming a negatively charged meshwork [8–10]. The
EG layer consists of a variety of endothelial membrane-
bound molecules, including glycoproteins and proteogly-
cans carrying negatively charged glycosaminoglycans (i.e.,
heparan sulfate, chondroitin sulfate, and hyaluronic acid).
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The EG layer plays an important role in fluid and solute
movement across capillaries, mechanotransduction that
couples shear stress to endothelial cell responses, and neu-
trophil adhesion to the endothelial cell surface [11]. The
EG structure is fairly stable under physiological condi-
tions, striking a balance between the synthesis of new
glycans and shear-dependent shedding of exiting glycans.
Degradation of the EG layer is closely associated with the
pathophysiology of inflammation, capillary leakage, and
edema formation in surgical injuries and disease states,
including ischemia-reperfusion injury, sepsis, trauma, and
hypervolemia [11]. Once destroyed, full restitution of the
EG layer requires several days [12].
The EG layer is in a dynamic equilibrium with plasma
proteins, forming a flexible gel-like structure called the
endothelial surface layer (ESL) [8]. The ESL acts as a
barrier to fluid and large molecules, has a thickness even
achieving a magnitude of over 1 μm, and thus physiolo-
gically occupies approximately 25 % of the total intravas-
cular space [12]. Consistent with this, Vink and Duling
[13] demonstrated that dextrans with a molecular weight
larger than 70,000 Da failed to penetrate the ESL in
hamster cremaster muscle capillaries (ESL thickness
0.4–0.5 μm), whereas dextrans with a molecular
weight of 40,000 Da equilibrated with the ESL within
1 min, evidencing the important role of the ESL as a
molecular filter.
Capillary hydrostatic pressure
Due to capillary hydraulic resistance, blood pressure falls
along a capillary from the arterial end (e.g., 32–36 mmHg
for human skin) to the venous end (e.g., 12–25 mmHg
for human skin), and thus, capillary hydrostatic pressure
(PC) lies between hydrostatic pressure in the arteriole
(PA) and that in the venule (PV) [14]. As blood flow from
arterioles to mid-capillaries (i.e., [PA–PC]/RA, where RA
is hydraulic resistance in arterioles) is equal to the blood
flow from mid-capillaries to venules (i.e., [PC–PV]/RV,
where RV is hydraulic resistance in the venule) in the
steady state, PC can be described by an equation
(Pappenheimer-Soto Rivera) that includes PA, PV, and
the ratio of precapillary arteriolar resistance to post-
capillary venular resistance [RA/RV] (see box in Fig. 1)
[14]. The increase of PA or PV increases PC, but as RA/RV
is large (~4) under normal conditions, PC is more sensitive
to PV than PA and is more similar to PV than PA (Fig. 1).
Further increase in RA/RV due to vasoconstriction drops
PC (i.e., rightward in the PC curve in Fig. 1), whereas a
decrease in RA/RV due to vasodilation increases PC (i.e.,
leftward in the PC curve in Fig. 1) [14]. Given that mean
arterial pressure (MAP) and intravascular volume modu-
late PA and PV, and a balance of vascular tones in the
arteriole and venule determines RA/RV, PC varies in a
rather complicated fashion in the clinical context [15]. For
example, sodium nitroprusside and nitroglycerin, both of
which are vasodilators, affect PC differently [16]. When
MAP was reduced to 40 mmHg by these drugs in striated
muscle vessels in hamsters, sodium nitroprusside in-
creased PC from 22 mmHg (i.e., baseline) to 26 mmHg,
whereas nitroglycerin decreased PC from 22 mmHg (i.e.,
baseline) to 17 mmHg. Given that both drugs decreased
RA by 80 % compared to the baseline, the difference was
explained by the contrasting effects of these drugs on RV
in that sodium nitroprusside increased RV by 40 %
whereas nitroglycerin decreased RV by 40 % compared to
the baseline.
Effects of capillary hydrostatic pressure on capillary fluid
filtration and colloid permeation
According to the revised Starling equation, transendothe-
lial pressure differences and plasma-subglycocalyx colloid
osmotic pressure (COP) differences are central to fluid
filtration, with interstitial COP being negligible [14, 17].
Proteins in plasma can diffuse into the interstitium via
large pores (50–60 nm in diameter) in fenestrated capil-
laries (e.g., capillaries in kidneys and intestinal mucosa).
Fig. 1 Theoretical prediction of capillary hydrostatic pressure as a
function of ratio of hydraulic resistance in arterioles to venules.
Capillary hydrostatic pressure (PC) was obtained from the equation
in the box on PC (i.e., the Pappenheimer-Soto Rivera equation). The
equation is determined by hydrostatic pressures in the arteriole (PA)
and venule (PV) and the ratio of hydraulic resistance of the arteriole
(RA) to that of the venule (RV) (i.e., RA/RV) assuming that blood flow
is constant through the capillary (arrow in the figure in the box).
Increased PA (without change of PV) or increased PV (without change
of PA) increases PC compared to the normal state. Vasodilation
increases PC (i.e., leftward in the PC curve), while vasoconstriction
decreases PC (i.e., rightward in the PC curve). PC varies in a rather
complicated fashion in the clinical setting due to different changing
patterns of PA, PV, and RA/RV. The pressure values of PA and PV are
expressed in mmHg. Shaded area denotes the normal value of RA/RV
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Fenestrated capillaries are at least an order of magnitude
more permeable to water and small hydrophilic solutes
than continuous capillaries (e.g., capillaries in skeletal
muscle, skin, and lungs) [14]. Subglycocalyx protein con-
centration that determines COP in the subglycocalyx
space is determined by the rates of upstream diffusion
and downstream washout [14, 17] (Fig. 2a). Under a nor-
mal PC (approximately 25 cmH2O) and filtration rate,
COP in the subglycocalyx space may be 70–90 % of that
in the interstitium. However, at a low filtration rate,
plasma proteins entering the interstitium via the large
pore accumulate there, raising the interstitial protein
concentration. Accumulated plasma protein diffuses more
easily up the cleft, raising the concentration of subglycoca-
lyx protein (i.e., upstream diffusion). In contrast, a high fil-
tration rate dilutes subglycocalyx protein via downstream
washout, leading to a decrease in subglycocalyx protein
concentration (Fig. 2a).
These features in fluid filtration across the EG layer
affect fluid movement during fluid administration. At
subnormal PC, transcapillary flow approaches zero with
a minimal COP difference [18, 19] (Fig. 2b). In this situ-
ation, both crystalloid and colloid solutions are retained
in the intravascular space until transcapillary flow
resumes [19, 20]. In contrast, at supranormal PC, the
COP difference is maximal, and thus, fluid movement
depends on the transendothelial pressure difference
(Fig. 2b). When a colloid solution is infused in this
situation, it maintains COP by distributing through the
plasma while increasing PC, and this increases fluid
filtration. A crystalloid solution in the same situation
lowers plasma COP but increases PC, and thus, fluid filtra-
tion increases more than with a colloid solution [19, 20].
PC can affect capillary permeability of colloid molecules.
A mathematical model describing fluid and albumin fluxes
in the EG layer demonstrated that in the steady state, a
slight reabsorption of albumin (i.e., from the subglycocalyx
space to the capillary) occurs at low PC, whereas albumin
convection flux (i.e., from the capillary to the interstitium)
increases at high PC [18]. Chen and Fu [21] developed an
electrodiffusion model describing the transport of macro-
molecules across the EG layer. The model demonstrated
that albumin permeability across the layer is attenuated by
the negative charge of EG, and the increase in PC from
15 cmH2O to 30 cmH2O doubles albumin permeability
across the EG layer through a convection mechanism. In-
creases in macromolecule permeability across the EG
layer at high PC is also observed with neutral macromole-
cules (e.g., HES) [21]. The larger the macromolecule, the
larger the effect PC has on permeability across the EG
layer. These findings suggest that PC plays a crucial role in
volume expansion by colloid solutions via the control of
fluid filtration and permeation of colloid molecules across
the EG layer.
These characters might provide us a new insight to a
choice of colloid solution infusion or vasopressor use for
critically ill patients. When PC is high in well-perfused
dilated capillaries in the conditions such as after fluid
volume loading at the induction of anesthesia and early
Fig. 2 a Effects of fluid filtration (Jv) across capillaries on subglycocalyx
albumin concentration. Albumin entering into the interstitium
via a large pore (Js, solid arrow in black) diffuses backwards into
the subglycocalyx space according to concentration gradients
(i.e., upstream diffusion, dotted arrow in black). Fluid filtration across the
endothelial glycocalyx (EG) layer dilutes albumin in the subglycocalyx
space (i.e., downstream washout, dotted arrow in white). Cited from
reference [17] with permission. ESL endothelial surface layer, PC, Pi
hydrostatic pressure in the capillary and interstitium, respectively,
πc, πi, πg colloid osmotic pressure in the capillary, interstitium, and
subglycocalyx space, respectively. b Effects of capillary hydrostatic
pressure (PC) on albumin concentration along the endothelial
glycocalyx (EG) layer. ESL endothelial surface layer, πi, πg colloid osmotic
pressure in the interstitium and subglycocalyx space, respectively.
Normal PC is approximately 25 cmH2O. Cited from reference [18]
with permission
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sepsis after fluid volume loading, volume effect of colloid
solution is reduced (Fig. 3, lower left panel). In this con-
text, lowering PC to the normal value by appropriate use
of vasopressor can increase volume effect of colloid
solution. Contrarily, PC is low in collapsed capillary in
the hypovolemic conditions such as hemorrhage shock
during surgery or trauma and early sepsis before fluid
volume loading. Most of the infused colloid solution is
retained in the intravascular space, whereas excessive
use of vasopressor can worsen tissue perfusion by fur-
ther lowering PC (Fig. 3, lower right panel).
Experimental and clinical evidence
Context-sensitive volume effects of fluid solutions
It was long believed that only 20 % of infused crystalloid
remains in the intravascular space, whereas most colloid
solutions, such as HES solution, remain in the intravas-
cular space. Although this is true for healthy individuals,
it is not the case for patients with hemorrhage or those
undergoing general anesthesia.
Given that plasma volume measurement using the dye
dilution technique is time-consuming and thus not suit-
able for real-time measurement, a volume kinetics method
based on changes in hemoglobin concentration has been
developed to measure plasma volume changes after fluid
administration [22]. In males, plasma dilution following
administration of 25 ml kg−1 Ringer’s acetate solution, as
assessed by changes in hemoglobin concentration, was
larger after 900 ml of blood had been withdrawn
compared to when they were normovolemic [23] (Fig. 4).
Volume kinetic analysis revealed that the observed in-
crease of plasma volume expansion for crystalloid solution
in the hypovolemic state (i.e., after blood withdrawal) can
be attributed to a decrease in elimination clearance from
the intravascular space. The increase in retention of crys-
talloid solution in the intravascular space was also ob-
served during general [24, 25], spinal [24], and epidural
[25] anesthesia. This effect was attributed to a decrease in
fluid shift from the intravascular space to the extravascular
space (i.e., interstitium), the magnitude of which increased
with the decrease of MAP [22].
The context-sensitive volume effect also applies to col-
loid solutions.
Rehm et al. [26] measured blood volume changes during
acute fluid volume loading of 6 % HES 200/0.5 (average
molecular weight, 200,000 Da) and 5 % albumin solutions
(20 ml kg−1 over 15 min) at the induction of general
anesthesia. Plasma volumes were measured before and
30 min after the end of fluid infusion by the dilution
technique using indocyanine green and hematocrit
changes. Increases of blood volume after volume loading
of HES 200/0.5 and 5 % albumin solutions were 43 and
38 % of the infused fluid volume, respectively. These
volume effects were much smaller compared to those dur-
ing isovolemic hemodilution (20 ml kg−1 of blood with-
drawal) in that approximately 90 % of infused HES 200/0.5
Fig. 3 Proposed effects of capillary hydrostatic pressure (PC) on fluid flow and hydroxyethyl starch (HES) permeation across capillaries. The increase in
PC resulting from vasodilation increases fluid flow and HES permeation across capillaries (lower left panel). The use of vasopressors attenuates the
increases in fluid flow and HES permeation across capillaries by normalizing PC. When PC is low in collapsed capillary under hypovolemia, most of the
infused HES solution is retained in the intravascular space (lower right panel), whereas vasopressor worsens tissue perfusion by further lowering PC.
ESL endothelial surface layer
Tatara Journal of Intensive Care  (2016) 4:20 Page 4 of 12
and albumin solutions were retained in the intravascular
space [7, 27].
The most remarkable finding in that study [26] was
that the ratio between whole body hematocrit (i.e.,
erythrocyte volume divided by the sum of plasma
volume and erythrocyte volume) and large vessel
hematocrit (i.e., hematocrit of arterial blood sample)
significantly increased after fluid volume loading at the
induction of general anesthesia compared to before
infusion (0.95 vs. 0.84 for HES 200/0.5; 0.93 vs. 0.83 for
albumin). This ratio reflects that noted between distribu-
tion spaces for indocyanine green and erythrocytes, in
which indocyanine green distributes into the ESL due to
its low molecular weight, whereas erythrocytes cannot
distribute into this layer (Fig. 5). Accordingly, the
increase in ratio between whole body hematocrit and
large vessel hematocrit after colloid infusion suggests
that volume loading of colloid solutions thinned the
ESL. The authors proposed that these effects of colloid
solutions on the ESL were caused by a release of atrial
natriuretic peptide during iatrogenic acute hypervolemia.
This scenario was confirmed by another clinical study
showing that volume loading of 6 % HES 130/0.4 solu-
tions (20 ml∙kg−1 over 15 min) increased release of atrial
natriuretic peptide (by 100 %) and increased serum con-
centrations of hyaluronic acid and syndecan-1 (both by
80 %), both of which are constituents of the ESL [28].
Consistent with this, pig studies have found that atrial
natriuretic peptide induces the shedding of the EG layer
and enhances vascular permeability [29, 30].
Clinically, perturbations of the EG layer and ESL can
range from deterioration of the ESL (e.g., aggressive fluid
administration) to destruction of the EG layer (e.g., sepsis)
[12]. Septic shock patients exhibited an increase in plasma
levels of heparan sulfate and hyaluronic acid to fourfold
that of controls, whereas levels of chondroitin sulfate did
not differ between groups [31]. The enzymatic removal of
glycosaminoglycans of the EG layer in post-capillary
venules in rats reduced the thickness of the EG layer, but
the effects on solute permeability of the EG layer were
inconsistent across enzymes [32]. Chondroitinase and
hyaluronidase increased the permeability of dextran with
Fig. 4 Time course of plasma dilution following crystalloid infusion
in volunteers under normovolemia and after blood withdrawal.
Ringer’s acetate solution (25 ml kg−1) was intravenously infused over
30 min to male volunteers when they were normovolemic and after
900 ml of blood had been withdrawn. Plasma dilution (no unit) was
indicated by blood hemoglobin changes. Cited from reference [23]
with permission
Fig. 5 a Electron micrograph showing the endothelial glycocalyx in
a capillary of the rat left ventricular myocardium, as indicated by an
Alcian blue 8GX staining. Cited from reference [9] with permission.
b Schema representing a difference of plasma volume measured by
dye dilution and hematocrit dilution. Dye (i.e., indocyanine green)
diffuses into the endothelial surface layer (ESL) and thus measures
plasma volume inside the red thick line, whereas hematocrit reflects
plasma volume excluding the ESL (red dotted line)
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a molecular weight of 70,000 Da across the EG layer,
whereas heparinase decreased it. This discrepancy may be
explained by a collapse of the EG layer due to the removal
of heparan sulfate, which compacts the EG layer to main-
tain a constant resistance to filtration [32].
Effects of fluid rate on plasma volume expansion
Under conditions that cause capillary leakage, such as
sepsis, the infusion rate of colloid solution influences the
volume expansion effects of colloid solutions. Rapid in-
fusion of colloid solutions can transiently increase arter-
ial and venous pressures. The resultant increase in PC
augments capillary leakage of fluid and colloids from the
intravascular space to the interstitium, and thus reduces
the volume expansion effects of colloid solutions. This
hypothesis was supported for albumin, gelatin, and HES
130/0.4 (average molecular weight 130,000 Da) in a sep-
tic rat model [33], and for dextran and albumin in a sep-
tic pig model [34]. In the former study, rapid infusion of
5 % albumin solution and 6 % HES 130/0.4 solution
(12 ml kg−1 over 15 min) increased MAP but decreased
plasma volume expansion at 3 h after the initiation of
fluid infusion compared to slow infusion of these
solutions (12 ml kg−1 over 3 h) (−3 vs. 3 ml kg−1 for
albumin; −6 vs. −2 ml kg−1 for HES 130/0.4).
Effects of vasopressors on plasma volume expansion
The dependence of plasma volume on MAP was demon-
strated in post-cardiac surgery patients who required
norepinephrine to treat vasodilatory shock [35]. The in-
fusion rates of norepinephrine were randomly adjusted
to maintain MAP at 60, 75, or 90 mmHg for 30 min.
Plasma volume calculated by hematocrit changes de-
creased by 6.5 and 9.4 % when MAP was increased from
60 to 75 mmHg and from 60 to 90 mmHg, respectively.
Norepinephrine, in general, decreases PC via arteriole
vasoconstriction (Fig. 1) but can also constrict venules.
The resultant increase in PV may increase PC under con-
ditions of increased MAP (i.e., PA). Therefore, these
findings suggest that the increase in PC resulting from a
norepinephrine-mediated increase in MAP augments
transcapillary fluid extravasation, leading to plasma
volume loss.
These effects of norepinephrine on plasma volume
changes depend on intravascular volume. In one study
using rats with increased capillary permeability due to
anaphylactic reaction, plasma volume changes following
the infusion of 5 % albumin solution were measured with
the albumin tracer technique [36]. The norepinephrine-
induced increase in blood pressure reduced plasma
volume, the magnitude of which was much greater under
increased capillary permeability compared to normal
capillary permeability. However, the plasma-reducing
effect of norepinephrine was less pronounced under
hypovolemia, suggesting that the decrease in PC due to
hypovolemia results in the retention of more fluid in the
intravascular space, thereby attenuating the plasma-
reducing effect of norepinephrine compared to the nor-
movolemic state.
Context-sensitive fluid therapy
Gap between macro-hemodynamics and microcirculation
The restoration of microcirculation is essential for the
improvement of outcomes in critically ill patients.
Nevertheless, as the assessment of microcirculation at
the bedside is difficult, more readily measureable macro-
hemodynamic parameters, such as arterial pressure and
cardiac output, are used as surrogates, with the assump-
tion that microcirculatory perfusion is coupled to
macro-hemodynamics. However, in shock states arising
from sepsis and hemorrhage, the relationship is dis-
rupted such that microcirculatory organ perfusion may
be abnormal despite restoration of seemingly adequate
macro-hemodynamic parameters [37].
In traumatic hemorrhage shock patients, despite res-
toration of macro-hemodynamics, sublingual microcir-
culation was impaired for at least 72 h [38]. Given that
this applies to major surgery with massive hemorrhage,
the restoration of macro-hemodynamic circulation may
not equate to the preservation of microcirculation. In
patients undergoing high-risk major abdominal surgery,
the density and proportion of sublingual perfused capil-
laries was lower in patients who subsequently developed
postoperative complications than those with an unevent-
ful postoperative course [39].
Phase of illness
Critically ill patients largely differ not only by a type of in-
sult but also by disease phase. Hoste et al. [40] proposed
four phases of intravenous fluid therapy for critically ill pa-
tients: rescue, optimization, stabilization, and de-escalation.
The “rescue” phase involves aggressive administration of
fluid solution for the immediate management of life-
threatening conditions associated with impaired tissue
perfusion, such as septic shock and major trauma. The
“optimization” phase involves adjusting the fluid type, rate,
and amount based on clinical condition in order to
optimize tissue perfusion, such as during major surgery.
The “stabilization” phase aims for a zero or negative fluid
balance by minimal maintenance infusion, such as during
stays at the intensive care unit (ICU) after major surgery.
The “de-escalation” phase involves minimization of fluid
administration and mobilization of extra fluids to optimize
fluid balance, such as during the recovery phase.
Anesthesia
Most general anesthetics have vasodilating action [41, 42].
It has been a common practice to administer a large
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amount of fluid to treat the resultant hypotension,
especially at the induction of general anesthesia. However,
this treatment lacks rationale because overnight fasting
does not significantly decrease plasma volume in low-risk
surgical patients [43]. Given that PC is increased by vaso-
dilation and fluid volume loading at the induction of
anesthesia (Fig. 6a, blue line), the volume effect of infused
fluid is attenuated as a result of increased fluid filtration
and colloid permeation across capillaries. Accordingly,
the rational therapy for hypotension caused by anes-
thetics is the appropriate use of vasopressors that
normalize the decreased vascular tone (Fig. 6a, red
broken line), allowing for the retention of more infused
fluid in the intravascular space.
Vasopressors, such as norepinephrine, increase tissue
perfusion pressure, but there remains a potential risk
that the resulting vasoconstriction impairs microcircula-
tory blood flow in vulnerable organs, such as the intes-
tinal tract and kidneys, to hypovolemia. In a pig model
of abdominal surgery (i.e., laparotomy of 4-h duration)
with low volume replacement (3 ml kg−1 h−1 of Ringer’s
lactate solution), the infusion of norepinephrine to
increase MAP to 65 mmHg (0.04 μg kg−1 min−1) and
75 mmHg (0.12 μg kg−1 min−1) did not adversely affect
microcirculatory blood flow or tissue oxygen in the in-
testinal tract [44]. However, given that hypovolemia was
not remarkable in that model, this result cannot be ex-
trapolated to conditions of severe hypovolemia arising
from massive hemorrhage during prolonged major ab-
dominal surgery or those requiring higher infusion rates
of norepinephrine.
Sufficient cardiac preload is indispensable for optimiz-
ing cardiac output.
Cardiac preload is determined by venous return, which
is equal to the difference between mean systemic filling
pressure and right atrial pressure divided by the re-
sistance to venous flow return [6]. Veins of the systemic
circulation contain approximately 70 % of the blood
volume in the whole body. This highly distensible fluid
component consists of an unstressed volume and a
stressed volume, occupying approximately 70 and 30 %
of the total volume of the venous system, respectively
[5]. The unstressed volume is the volume of blood in a
vein at transmural pressure equal to zero (i.e., pressure
within the vessel is equal to that outside the vessel) and
thus does not directly contribute to venous return. In
contrast, the stressed volume represents blood volume
above the opening and thus contributes directly to mean
systemic filling pressure and venous return. Changes in
vascular tone alter the ratio of unstressed to stressed
volume [5, 6]. Specifically, venoconstriction shifts blood
from unstressed volume to stressed volume, whereas
venodilation shifts blood from stressed volume to un-
stressed volume. Hemorrhage decreases stressed volume,
while fluid administration increases it.
Given that general anesthetics decrease venous tone as
confirmed for pentobarbital [45] and volatile anesthetics
(e.g., sevoflurane) [46], anesthetics increase unstressed
volume and decrease stressed volume. Resultant de-
crease of mean systemic filling pressure decreases ven-
ous return and thus cardiac output. In this context, a
large amount of fluid volume loading is required to
increase mean systemic filling pressure to the level that
restores venous return to the normal value. Therefore,
venoconstriction by appropriate use of vasopressor is ra-
tional because it recruits blood from enlarged unstressed
Fig. 6 Theoretical prediction of capillary hydrostatic pressure as a
function of ratio of hydraulic resistance in arterioles to venules
during general anesthesia (a), in the hypovolemic state (b), and in
sepsis (c). The values of capillary hydrostatic pressure (PC) were
calculated as a function of the ratio of hydraulic resistance of the
arteriole (RA) to that of the venule (RV) (i.e., RA/RV) using the equation
in the box (Fig. 1) on PC. PC values were simulated during general
anesthesia (a), in the hypovolemic state (b), and in sepsis (c) after
intervention of fluid volume loading or use of vasopressor at given
hydrostatic pressures (mmHg) in the arteriole (PA) and venule (PV).
Circle symbols in the curves denote assumed values of RA/RV
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volume to stressed volume and thus increases mean sys-
temic filling pressure and venous return.
Surgery
Ongoing hemorrhage and fluid shifts from the intravas-
cular space to the interstitium due to surgical trauma
cause hypovolemia during major abdominal surgery.
However, a higher infusion rate of crystalloid solution
(i.e., >10 ml kg−1 h−1), which is routine practice for
major abdominal surgery, does not contribute to the re-
covery of plasma volume but enhances interstitial edema
[47]. This phenomenon depends on surgical duration. In
a mathematical simulation for abdominal surgery, the
range of crystalloid infusion rates required to maintain
plasma volume and interstitial volume within critical
values (>−15 and <20 % of baseline values, respectively)
was wide for short-duration surgery (2–19 ml kg−1 h−1 for
a 2-h surgery), whereas it was narrow for long-duration
surgery (5–8 ml kg−1 h−1 for a 6-h surgery) [48].
Hypovolemia resulting from major abdominal surgery
decreases PC (Fig. 6b, red line). As the plasma volume
expanding effect of the infused fluid is increased in this
context, fluid administration is the first choice for treat-
ing hypotension resulting from hypovolemia (Fig. 6b,
blue line). Indeed, vasopressor can restore PC and main-
tain microcirculation by increasing MAP (Fig. 6b, red
broken line) and recruiting blood from the unstressed
volume to the stressed volume. However, in cases of
massive hemorrhage (e.g., >20 ml kg−1), unstressed blood
volume is already reduced by an increase in sympathetic
discharge as compensation to the decreased circulating
blood volume. In this context, aggressive use of vasopres-
sor is detrimental given that it does not induce further
recruiting of blood from the unstressed volume and thus
impairs microcirculation by further lowering PC [49].
However, aggressive fluid infusion transiently causes
hypervolemia, leading to a decrease in the volume
expanding effects of the aforementioned fluid solution [7].
Therefore, infusion of a relatively small volume of fluid so-
lution (e.g., 3–4 ml kg−1) over a short time (5–10 min)
should be repeated while observing hemodynamic re-
sponses to the infusion. Many recent clinical studies have
shown that goal-directed fluid therapy according to fluid
responsiveness (i.e., increase in stroke volume or cardiac
output following fluid bolus infusion above a certain level)
enables the stabilization of intraoperative hemodynamics
and improvement of postoperative outcomes following
major abdominal surgery [50–52]. In fluid therapy, fluid
volume loading is typically repeated until fluid responsive-
ness disappears, assuming that the heart is on the steep
portion of the Frank-Starling curve while fluid responsive-
ness is observed [53, 54]. However, the application of this
strategy to daily clinical practice is problematic [55]. For
example, the increase of cardiac preload following fluid
infusion may be inconsistent for each round of fluid
infusion due to context-sensitive volume expansion. The
absence of fluid responsiveness may simply be attributed
to inadequate increases in cardiac preload following infu-
sion. Accordingly, cardiac preload changes following every
fluid bolus should be confirmed by flow-related dynamic
parameters such as stroke volume variation (SVV) during
mechanical ventilation which is closely related to cardiac
preload [56].
Anastomotic leakage is a frequent complication of
major abdominal surgery. Given that inadequate tissue
perfusion can lead to anastomotic leakage, maintenance
of tissue perfusion by adequate fluid administration may
reduce the incidence of this complication. Kimberger
et al. [57] demonstrated, in a pig model of colon anasto-
mosis of 4-h duration, that goal-directed colloid admin-
istration (i.e., 3 ml kg−1 h−1 of Ringer’s acetate + bolus of
250 ml of 6 % HES 130/0.4) significantly increased
microcirculatory blood flow in healthy and injured colon
compared to goal-directed crystalloid administration
(i.e., 3 ml kg−1 h−1 of Ringer’s acetate + bolus of 250 ml
of Ringer’s acetate) or restrictive crystalloid fluid therapy
(i.e., 3 ml kg−1 h−1 of Ringer’s acetate). As the cardiac
index for goal-directed colloid administration was higher
than those for other fluid therapies, it is difficult to
separate the effects of systemic and regional hemo-
dynamics on the improvement of microcirculatory blood
flow in the colon for goal-directed colloid administra-
tion. Nevertheless, given that the splanchnic organs are
at risk of hypoperfusion from hypovolemic insults, this
finding confirms the scenario that improvements in
microcirculatory blood flow in the gastrointestinal tract
and colon contribute to the improvement of outcomes
after major abdominal surgery by goal-directed fluid
therapy using colloid solutions [52].
Norepinephrine infusion can reduce the total volume of
fluid solution administered during major surgery. A ran-
domized clinical study of radical cystectomy compared
total fluid volume and the incidence of postoperative com-
plications between a control group (6 ml kg−1 h−1 of bal-
anced Ringer’s solution) and a group in which restrictive
hydration (1–3 ml kg−1 h−1 of balanced Ringer’s solution)
was combined with preemptive norepinephrine infusion
to maintain MAP >60 mmHg (0.03–0.3 μg kg−1 min−1)
[58]. Norepinephrine decreased the total volume of
infused fluid solution by 60 % compared to the control
(3.6 vs. 9.3 ml kg−1 h−1) and reduced the rates of gastro-
intestinal and cardiac complications compared to the con-
trol (26 vs. 85 %).
Trauma
Intravenous fluid administration is a first treatment for
traumatic hemorrhage shock. However, as long as
hemorrhage is not controlled, the full restoration of
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blood pressure by aggressive crystalloid volume loading
may increase the risk of bleeding [59]. This is caused by
dilution of coagulation factors leading to coagulopathy
and increase of MAP that prevents clot formation [38].
According to the volume kinetic analysis, in normoten-
sive adult male volunteers who had 900 ml of blood re-
moved within 10–15 min, crystalloid infusion of 2700 ml
over 30 min resulted in hypervolemia by 600 ml [59]. The
crystalloid volume required to restore normovolemia was
1500 ml (i.e., 1.6 times the blood loss) much smaller com-
pared to that previously recommended (i.e., three to four
times the amount of blood loss) if fluid volume loading
was started immediately after the hemorrhage. This
finding is consistent with context-sensitive volume effect
of infused fluid in that hypovolemia increases volume
expanding effect of crystalloid solution [23]. Therefore,
treatment of trauma with uncontrolled hemorrhage
is “permissive resuscitation” that maintains MAP at
60 mmHg (i.e., avoid restoring MAP to normal levels) and
avoid hypervolemia resulting from aggressive fluid volume
loading [59].
Uncontrolled hemorrhage shock model in mice com-
pared fluid requirements, blood loss, and intestinal micro-
circulation between fluid (i.e., 0.9 % saline) resuscitation
with or without norepinephrine to target MAP at 50 and
60 mmHg [60]. The administration of norepinephrine
significantly decreased fluid requirements by 60 % for
MAP at 50 mmHg and 70 % for MAP at 60 mmHg com-
pared to resuscitation only with fluid. Blood loss was com-
parable between two treatments for MAP at 50 mmHg
but was halved by the use of norepinephrine compared to
resuscitation only with fluid for MAP at 60 mmHg. The
administration of norepinephrine with fluid volume load-
ing preserved intestinal villi microcirculation for MAP at
50 and 60 mmHg. This beneficial effect of a combination
of norepinephrine with fluid volume loading to reduce
fluid requirements and blood loss while preserving
microcirculation is attractive, but it remains to be con-
firmed in clinical trials observing outcomes from trau-
matic hemorrhage shock.
Sepsis
Sepsis occurs as a result of the systemic activation of in-
flammatory pathways by constituent parts of microorgan-
isms. Early sepsis is characterized by a hyperdynamic
vasodilatory state [61]. Fluid shift from the intravascular
space to the interstitium due to capillary leakage causes
hypovolemia and can decrease PC despite vasodilation
(Fig. 6c, red line). An important feature of microcircula-
tion during sepsis is the decrease in capillary density and
increase in heterogeneity of perfusion with non-perfused
capillaries in close vicinity to well-perfused capillaries [61].
In the initial stages of sepsis, aggressive fluid admi-
nistration is expected to restore microcirculation by
reopening collapsed capillaries (Fig. 6c, blue line), given
that low PC increases the plasma volume expanding
effect of the fluid solution. In severe sepsis and septic
shock patients, both passive leg raising and volume
expansion by normal saline or HES 130/0.4, increased
vessel density and vessel perfusion and reduced micro-
vascular heterogeneity in the sublingual microcircula-
tion, within 24 h or their admission to the ICU [62].
Increases in cardiac output may have been responsible
for the improved microcirculation. However, microcircu-
latory perfusion remained stable after cardiac output
was further increased, suggesting that the relationship
between improved microcirculation and increased car-
diac output is not linear [62]. The use of vasopressor
may preserve microcirculation via an increase of PC due
to increase of MAP (Fig. 6c, red broken line), but exces-
sive use of vasopressor may decrease volume expanding
effect of fluid solution and thus cause interstitial edema.
Moreover, a previous multicenter observational study
determined the influence of combined use of fluids and
vasopressors on hospital mortality in septic shock pa-
tients [63]. In that study, retrospective evaluation using
multivariable logistic regression showed that starting
vasopressor in the initial hour after onset of septic shock
without aggressive fluid administration may be detri-
mental given that pharmacologic vasoconstriction in the
presence of hypovolemia could further impair tissue
perfusion [63].
The benefit (e.g., reduced mortality) of early goal-
directed therapy for septic shock that was originally pro-
posed by Rivers et al. [64] has not been proven by recent
systemic review with meta-analysis of five randomized
clinical trials [65]. Given that early goal-directed therapy
for septic shock patients requires aggressive fluid volume
loading in the first 6 h based on MAP (≥65 mmHg), cen-
tral venous pressure (≥8 mmHg), central venous oxygen
saturation (≥70 %), and urine output (≥0.5 ml kg−1 h−1),
resultant fluid overload causes increased use of fluid-
related medical interventions such as diuresis and in-
creased hospital mortality [66].
Once PC is normalized by fluid administration, further
fluid infusion may cause hypervolemia. The resultant in-
crease in PC enhances fluid leakage from the intravascu-
lar space to the interstitium due to degradation of the
EG layer and ESL [1]. Therefore, aggressive fluid infu-
sion should be restricted during the initial stages of sep-
sis (i.e., within 24 h). In one study, severe septic patients
received 1000 ml of Ringer’s lactate solution or 400 ml
of 4 % albumin solution either within 24 h (early) or
more than 48 h (late) after a diagnosis of severe sepsis
[67]. The administration of both fluids improved sublin-
gual microvascular circulation in the early, but not late,
stages of sepsis. These effects were independent of global
hemodynamic effects and solution type.
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Link between capillary hydrostatic pressure and fluid
therapy in critical illness
Most frequent trigger for fluid volume loading in critical
illness is hypotension. Indeed, low MAP may decrease
PA, but low MAP does not necessarily imply low PC be-
cause PC is determined also by PV and RA/RV. Given that
PC plays a key role for the volume expanding effect of
fluid administration, strategy of fluid therapy differs by
PC (Table 1). However, monitoring PC is difficult in a
clinical setting, and therefore, we can only speculate
whether PC is low, normal, or high. A possible way to as-
sess PC is to observe hemodynamic responses to fluid
volume loading (i.e., fluid challenge).
The increase of MAP following fluid challenge may be
a surrogate for detecting fluid responsiveness in clinical
practice, but only 44 % of fluid responders (i.e., ≥10 %
increase in cardiac output after 500 ml of saline or HES
130/0.4 over 30 min) in one study for septic shock pa-
tients showed an increase in MAP of more than 10 %
from pre-infusion levels [68]. Fluid-induced reduction in
arterial load in responders may explain the discrepancy
between changes in MAP and cardiac output, given that
intravascular volume expansion blunts baroreflex-
mediated vasoconstriction in response to hypovolemia,
reduces vascular tone via flow-mediated vascular relax-
ation, and recruits previously closed vessels [68].
ICU patients with a low sublingual microvascular flow
index (MFI, <2.6) exhibited an increase in MFI after
fluid challenge (500 ml of saline or 6 % HES 130/0.4
over 30 min), whereas those with a high sublingual MFI
(≥2.6) showed no significant change [69]. However, fluid
responsiveness (i.e., 10 % increase of stroke volume after
fluid challenge) did not discriminate between MFI <2.6
or ≥2.6 at baseline. The discrepancy between MFI and
fluid responsiveness suggests that the relationship be-
tween fluid responsiveness and restoration of microcir-
culation is complex and that fluid responsiveness does
not imply the need for fluid therapy [69]. Given that low
microvascular flow is associated with low PC [14], the
finding might support the scenario that low PC increases
volume expanding effect of fluid solutions.
Fluid challenge that monitors flow-related dynamic pa-
rameters following fluid bolus infusion is a useful tool
for decision-making in fluid therapy [70]. For example, if
the patients are hypovolemic in the condition of low PC
with vasoconstriction, they are expected to show fluid
responsiveness (i.e., large increase of cardiac index or
stroke volume) with large decrease of SVV after fluid
challenge. In this context, fluid volume loading is effect-
ive to restore PC via a large volume expansion effect and
thus increases venous return and cardiac output.
Nevertheless, frequent fluid challenges result in exces-
sive fluid administration causing tissue edema [71]. A re-
cent study involving critically ill patients who were
mechanically ventilated showed that change of SVV after
mini-fluid challenge (100 ml colloid bolus during 1 min)
accurately predicted fluid responsiveness that was de-
fined as ≥15 % increase in cardiac index after the full
(500 ml) fluid challenge [72]. In that study, SVV de-
creased by 3 % after fluid challenge and resulted in an
increase of stroke volume index by 9.5 % for responders,
whereas for non-responders, SVV remained unchanged.
Given that SVV before fluid challenge was comparable
between responders and non-responders (12 vs. 13 %),
Table 1 Suggested fluid therapy to treat hypotension in critical illness on the theoretical basis of capillary hydrostatic pressure (PC)
Context PC Fluid volume loading Vasopressor Comments
Anesthesia ↑ (−) (+)
↓ (+) (+) Low MAP can decrease
PC despite vasodilation.
Surgery
Hemorrhage ↓ (+) Use only when MAP is too low to
preserve tissue perfusion.
Long-duration ↓ Restrict crystalloid infusion (e.g., 3 ml kg−1 h−1).
If hypovolemia is suspected, repeat crystalloid
or colloid bolus (e.g., 4 ml kg−1 over 10–15 min).





↓ (+) Use only when MAP is too low to
preserve tissue perfusion.
Avoid full restoration of MAP
(≥60 mmHg) because of a
risk of bleeding.
Sepsis





(+) recommended, (−) not recommended, MAP mean arterial pressure
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changes of SVV after fluid challenge rather than absolute
values of SVV before fluid challenge may determine fluid
responsiveness in those patients. Thus, mini-fluid chal-
lenge based on flow-related dynamic parameters may be
a promising method to predict the effectiveness of fluid
volume loading and possibly evaluate fluid status in crit-
ical illness given that it reduces a total amount of fluid
required for frequent fluid challenges.
Conclusions
Common to critically ill patients who undergo major sur-
gery or suffer from trauma or sepsis are microcirculatory
disturbances from capillary leakage due to inflammation.
Although fluid administration is useful for restoring
microcirculation by correcting hypovolemia, the volume
expanding effects of the fluid solution is context-sensitive.
A key element of these volume expanding effects may be
capillary hydrostatic pressure, which depends on arterial
pressure and vascular tone. The modulation of capillary
hydrostatic pressure through the appropriate use of vaso-
pressors might improve microcirculation and thus patient
outcomes by increasing the volume effectiveness of fluid
infusion and reducing the adverse effects of excessive fluid
infusion. There remains a large gap between fluid patho-
physiology based on the revised Starling equation and
fluid therapy in critical illness because of difficulties in
measuring capillary hydrostatic pressure in clinical set-
tings. Nevertheless, clinicians should be aware of possible
involvement of capillary hydrostatic pressure in a com-
plexity of fluid therapy in critical illness.
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